The skin tightening segment is expected to grow at the highest CAGR from 2017 to 2025.

By -

 Body contouring devices have gained a substantial market share in recent years due to rise in obesity globally. In addition, surge in esthetic consciousness across the globe is another major factor that in turn has fueled the use of body contouring devices. Furthermore, untapped potential in the emerging markets in Asia-Pacific is anticipated to boost the market growth in the future. 

The global body contouring devices market was valued at $933 million in 2017 and is projected to reach $3,446 million in 2025, registering a CAGR of 17.7% from 2018 to 2025.


The report segments the global body contouring devices market into product, application, end user, and region. Based on product, non-invasive devices contributed to nearly three-fifths of the total market share in 2017 and would grow at the highest CAGR of 18.1% from 2018 to 2025. This is due to its ability to offer lesser risk and pain as compared to traditional surgical devices and procedures. Based on application, skin tightening application held the major share in 2017 and is expected to grow at the largest CAGR of 18.3% from 2018 to 2025.

End users analyzed in the research include hospitals & clinics, medical spas, and laboratories. Hospitals & clinics contributed to nearly two-thirds of the total market share in 2017 and will dominate throughout the forecast period, owing to the availability of certified staff & physicians. Geographically, Asia-Pacific is expected to grow at the highest growth rate, with a CAGR of 19.0% from 2018 to 2025, owing to rise in obesity in different countries of the region and surge in demand for body shaping devices among men in South Korea.

Key findings of the Body Contouring Devices Market:

The minimally invasive devices segment accounted for one-third share of the global body contouring devices market in 2017.

The skin tightening segment is expected to grow at the highest CAGR from 2017 to 2025.

The hospital & clinic segment accounted for around two-thirds share of the global body contouring devices market in 2017.

Europe accounted for more than one-fourth share of the global market in 2017.

Asia-Pacific is expected to provide lucrative growth opportunities from 2017 to 2025.

Leading market players analyzed in the report include Allergan plc, Bausch Health Companies Inc., Hologic, Inc., Shanghai Fosun Pharmaceutical Group Co., Ltd., Erchonia Corporation, MicroAire Surgical Instruments, LLC, Cutera, Inc., InMode Aesthetic Solutions, Sciton, Inc., and El.En. S.p.A. (Asclepion Laser Technologies GmbH).

Comments

Post a Comment

Popular posts from this blog

Global Cancer pain market is segmented based on drug type, disease indication, and region.

By -
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Read more

U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

By -
Image
  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Read more